Literature DB >> 23232253

Mucopolysaccharidosis type II in a female carrying a heterozygous stop mutation of the iduronate-2-sulfatase gene and showing a skewed X chromosome inactivation.

Raul E Piña-Aguilar1, Gerardo R Zaragoza-Arévalo, Isabella Rau, Andreas Gal, Miguel A Alcántara-Ortigoza, Mónica S López-Martínez, Yuritzi Santillán-Hernández.   

Abstract

We report a Mexican girl showing the full blown clinical picture of mucopolysaccharidosis type II (MPSII). Iduronate-2-sulfatase (IDS) activity was low and she carried a heterozygous de novo c.1327C>T transition in exon 9, that changes codon 443 for a premature stop (TGA; p.Arg443(*)). Analysis of X-chromosome inactivation in androgen receptor (AR) locus showed a highly skewed ratio of 92:8 suggesting a functional hemizygosity with dominant expression of the mutant IDS and explaining the disease manifestation. This is one of the rare cases of females affected by MPSII due to the combined effect of a skewed X-chromosome inactivation and a de novo IDS mutation. We recommend that clinicians should consider the diagnosis of MPSII even in a girl without positive family history for this condition.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23232253     DOI: 10.1016/j.ejmg.2012.11.006

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  8 in total

1.  De novo MECP2 duplications in two females with intellectual disability and unfavorable complete skewed X-inactivation.

Authors:  Nathalie Fieremans; Marijke Bauters; Stefanie Belet; Jelle Verbeeck; Anna C Jansen; Sara Seneca; Filip Roelens; Elfride De Baere; Peter Marynen; Guy Froyen
Journal:  Hum Genet       Date:  2014-07-19       Impact factor: 4.132

2.  Identification of Intellectual Disability Genes in Female Patients with a Skewed X-Inactivation Pattern.

Authors:  Nathalie Fieremans; Hilde Van Esch; Maureen Holvoet; Gert Van Goethem; Koenraad Devriendt; Monica Rosello; Sonia Mayo; Francisco Martinez; Shalini Jhangiani; Donna M Muzny; Richard A Gibbs; James R Lupski; Joris R Vermeesch; Peter Marynen; Guy Froyen
Journal:  Hum Mutat       Date:  2016-05-25       Impact factor: 4.878

Review 3.  Dosage Compensation in Females with X-Linked Metabolic Disorders.

Authors:  Patrycja Juchniewicz; Ewa Piotrowska; Anna Kloska; Magdalena Podlacha; Jagoda Mantej; Grzegorz Węgrzyn; Stefan Tukaj; Joanna Jakóbkiewicz-Banecka
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

4.  Clinical manifestations in female carriers of mucopolysaccharidosis type II: a Spanish cross-sectional study.

Authors:  Encarna Guillén-Navarro; María Rosario Domingo-Jiménez; Carlos Alcalde-Martín; Ramón Cancho-Candela; María Luz Couce; Enrique Galán-Gómez; Olga Alonso-Luengo
Journal:  Orphanet J Rare Dis       Date:  2013-06-25       Impact factor: 4.123

5.  Skewed X-Chromosome Inactivation in a Korean Girl with Severe Mucopolysaccharidosis Type II.

Authors:  Hwa Young Kim; Man Jin Kim; Moon-Woo Seong; Jung Min Ko
Journal:  Ann Lab Med       Date:  2022-05-01       Impact factor: 3.464

Review 6.  Gene Therapy for Mucopolysaccharidosis Type II-A Review of the Current Possibilities.

Authors:  Paweł Zapolnik; Antoni Pyrkosz
Journal:  Int J Mol Sci       Date:  2021-05-23       Impact factor: 5.923

7.  Detailed pedigree analyses and prenatal diagnosis for a family with mucopolysaccharidosis type II.

Authors:  Chuan Zhang; Shengju Hao; ZhaoYan Meng; Ling Hui; Yan Wang; Feng Xuan; Xue Chen; Xing Wang; Furong Zheng; Lei Zheng; Bingbo Zhou; Xinqi Wu; Qinghua Zhang; Zongfu Cao
Journal:  BMC Med Genomics       Date:  2021-06-30       Impact factor: 3.063

Review 8.  Biochemical and molecular analysis in mucopolysaccharidoses: what a paediatrician must know.

Authors:  Mirella Filocamo; Rosella Tomanin; Francesca Bertola; Amelia Morrone
Journal:  Ital J Pediatr       Date:  2018-11-16       Impact factor: 2.638

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.